SummaryMillions in India face a "diagnostic odyssey," enduring years of medical uncertainty for rare genetic conditions. Families often face fragmented care and financial strain before finding answers. By prioritizing early genomic sequencing over traditional symptomatic treatment, healthcare can shorten this painful journey, providing families with vital clarity and targeted care.